Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial.

ABSTRACT:

Background

Targeted axillary dissection (TAD) is an established method for axillary staging in patients with breast cancer after neoadjuvant chemotherapy (NAC). TAD consists of sentinel lymph node biopsy and initially pathological lymph node excision, which must be marked by a reliable marker before NAC.

Methods

The IMTAD study is a prospective multicentre trial comparing three localisation markers for lymph node localisation (clip + iodine seed, magnetic seed, carbon suspension) facilitating subsequent surgical excision in the form of TAD. The primary outcome was to prospectively compare the reliability, accuracy, and safety according to complication rate during marker implantation and detection and marker dislodgement.

Results

One hundred eighty-nine patients were i

SUBMITTER: Zatecky J 

PROVIDER: S-EPMC10439625 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature